Will your breakfast ruin this cancer pill? new trial investigates
Knowledge-focused
Not yet recruiting
This early-stage trial in 24 healthy adults examines how food and a common stomach-acid reducer (a proton pump inhibitor) change the way the body absorbs a new drug called VRN101099, which is being developed for solid tumors. Researchers will measure drug levels in the blood and …
Phase: PHASE1 • Sponsor: Voronoi, Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC